Cargando…
Silencing of Sphingosine kinase 1 Affects Maturation Pathways in Mouse Neonatal Cardiomyocytes
Sphingosine kinase-1 (Sphk1) and its product, sphingosine-1-phosphate (S1P) are important regulators of cardiac growth and function. Numerous studies have reported that Sphk1/S1P signaling is essential for embryonic cardiac development and promotes pathological cardiac hypertrophy in adulthood. Howe...
Autores principales: | Jozefczuk, Ewelina, Szczepaniak, Piotr, Guzik, Tomasz Jan, Siedlinski, Mateusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037404/ https://www.ncbi.nlm.nih.gov/pubmed/33807180 http://dx.doi.org/10.3390/ijms22073616 |
Ejemplares similares
-
Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1
por: Józefczuk, Ewelina, et al.
Publicado: (2020) -
Vascular transcriptome profiling identifies Sphingosine kinase 1 as a modulator of angiotensin II-induced vascular dysfunction
por: Siedlinski, Mateusz, et al.
Publicado: (2017) -
Systemic and local vascular inflammation and arterial reactive oxygen species generation in patients with advanced cardiovascular diseases
por: Sulicka-Grodzicka, Joanna, et al.
Publicado: (2023) -
Hypertensive Effect of Downregulation of the Opioid System in Mouse Model of Different Activity of the Endogenous Opioid System
por: Skiba, Dominik S., et al.
Publicado: (2021) -
Insulin Protects Apoptotic Cardiomyocytes from Hypoxia/Reoxygenation Injury through the Sphingosine Kinase/Sphingosine 1-Phosphate Axis
por: Yu, Huan, et al.
Publicado: (2013)